Skip to main content
. Author manuscript; available in PMC: 2013 Sep 18.
Published in final edited form as: J Acquir Immune Defic Syndr. 2011 Jan 1;56(1):e1–e8. doi: 10.1097/QAI.0b013e3181ff0bdc

Table 3. Proportions of patients with (i) viral load suppression at 16 weeks and (ii) CD4 cell count ≤200 cells/μl after 48 weeks stratified according to year of ART initiation.

Total period 2002/4 2004/5 2005/6 2006/7 2007/8 P-value
Viral load <400 copies/ml at week 16 2 248 (94.3) 315 (96.3) 388 (93.3) 574 (93.5) 497 (96.0) 474 (93.1) 0.091
CD4 count ≤200 cells/μl at week 48 588 (25.3) 96 (29.4) 155 (31.1) 120 (21.5) 121 (25.2) 96 (20.8) <0.001
†

Data available from 75.4% (n=2384) of patients retained

*

Data available from 73.5% (n=2325) of patients retained